Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989–1999)

Abstract

Results suggest that streptozocin can be administered safely to dogs at a dosage of 500 mg/m2, IV, every 3 weeks when combined with a protocol for induction of diuresis and may be efficacious in the treatment of dogs with metastatic pancreatic islet cell tumors.